Denosumab Injection for Osteoporosis from China
Prolia-brand denosumab, RANKL inhibitor antibody in 60mg prefilled syringes for retail, preventing bone resorption through immunological modulation. HTS 3002.15.00.91 for antibody-based immunological products in retail measured forms.
Duty Rate — China → United States
0%
Rate breakdown
9903.05.860%Universal product exemption (U.S. note 52(b))
Import Tips
• Include patient information leaflets to prove retail intent
• Validate against EU/ICH stability guidelines for transborder shipments